Loading resource…

SepNet Critical Care Trials Group
The study involved 440 adults with septic shock treated with albumin or standard fluid therapy across 23 intensive care units in Germany. The trial aimed to determine if albumin supplementation could reduce mortality rates in this patient population. Despite the hypothesis, the study found no significant difference in 90-day mortality between the albumin group and the control group. The trial was terminated prematurely due to low enrollment rates.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

VASOPRESSORS OR FLUIDS IN EARLY SEPTIC SHOCK
Same clinical topic · Critical Care Medicine

LOWER VS HIGHER FLUID VOLUMES IN ADULT PATIENTS WITH SEPSIS - AN UPDATED SYSTEMATIC REVIEW WITH META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS
Same clinical topic · Critical Care Medicine

INTERNATIONAL ANALGESIA AND SEDATION WEANING AND WITHDRAWAL PRACTICES IN CRITICALLY ILL ADULTS: THE ADULT IATROGENIC WITHDRAWAL STUDY IN THE ICU
Same clinical topic · Critical Care Medicine

HEPARIN-INDUCED THROMBOCYTOPAENIA
Same clinical topic · Critical Care Medicine

WHEN AND HOW MUCH? STEROIDS IN SEPSIS
Same clinical topic · Critical Care Medicine

THE ACID-BASE EFFECTS OF ALBUMIN IN SEPSIS: RECONCILING THE STEWART PHYSICOCHEMICAL APPROACH WITH THE TRADITIONAL BUFFER-BASE PARADIGM
Same clinical topic · Critical Care Medicine

Intubation in the Critically Ill: When, How, and How Long?
Same clinical topic · Critical Care Medicine

STATE - OF - THE - ART REVIEW: ß - BLOCKADE IN CRITICAL ILLNESS
Same clinical topic · Critical Care Medicine

STATE - OF - THE - ART REVIEW: ß - BLOCKADE IN CRITICAL ILLNESS
Same clinical topic · Critical Care Medicine